Texas

Resilience System


You are here

Africa

ANALYSIS of the difficulties in comparing vaccines

Yusuff Adebayo Adebisi knows that a vaccine that offers 70% protection against COVID-19 could be a valuable tool against the coronavirus pandemic in Nigeria — especially if that vaccine is cheap and doesn’t have to be stored at extremely cold temperatures. But what if another vaccine — one that is more expensive to buy and to store — was 95% effective?

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

NIH to launch research into Covid long term effects, plus international roundup

Roundup:  NIH to study ‘long-haul’ virus symptoms

  WASHINGTON  (AP) — The National Institutes of Health is launching research to understand the causes and consequences of the lingering brain fog, breathing problems and malaise reported by many recovering COVID-19 patients.

Dr. Anthony Fauci says some studies have shown up to 30% of patients report symptoms that can endure for months, complicating their return to normal routines and work, and plunging many recovering patients into depression.

Fauci noted at a White House coronavirus briefing on Wednesday that work at NIH started this week thanks to more than $1 billion provided by Congress for COVID-related medical research. Government scientists are looking to enlist doctors and research institutions around the country in the effort to learn about “long-haul” COVID-19.

Problem, Solution, SitRep, or ?: 

WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use

WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

Problem, Solution, SitRep, or ?: 

WHO expert group recommends use of AstraZeneca vaccine

GENEVA (AP) — Independent experts advising the World Health Organization about immunization on Wednesday recommended the use of AstraZeneca’s vaccine even in countries that turned up worrying coronavirus variants in their populations.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Africa
howdy folks
Page loaded in 0.687 seconds.